Document is current
Any future updates will be listed below
-
Authors
Pinheiro, Maisa
Wentzensen, Nicolas
Dean, Michael http://orcid.org/0000-0003-2234-0631
Yeager, Meredith http://orcid.org/0000-0003-3871-2225
Chen, Zigui
Shastry, Amulya http://orcid.org/0009-0007-8866-2357
Boland, Joseph F.
Bass, Sara
Burdett, Laurie
Lorey, Thomas
Mishra, Sambit http://orcid.org/0000-0001-8319-0599
Castle, Philip E.
Schiffman, Mark
Burk, Robert D. http://orcid.org/0000-0002-8376-8458
Zhu, Bin http://orcid.org/0000-0003-0172-5516
Mirabello, Lisa http://orcid.org/0000-0001-8485-0106
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (Intramural funds)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (HHSN261200800001E, CA78527, CA238592)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 13 August 2024
First Online: 12 September 2024
Competing interests
: M.P. is currently an employee of GlaxoSmithKline, J.F.B. and S.B. are now employees of AstraZeneca, and Amulya Shastry is now a doctoral student at Boston University, but they all completed the work associated with this project while employed at the National Cancer Institute. P.E.C. has received HPV tests and assays at a reduced or no cost for research from Roche, Becton Dickinson, Cepheid and Arbor Vita Corporation. All other authors declare no competing interests.
